Hysan Schnupfenspray Kinder (Xylometazoline Hydrochloride)

Xylometazoline is a selective alpha‑adrenergic agonist. When sprayed into the nose it binds to alpha‑1 receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces vascular leakage and edema, leading to decreased nasal obstruction and easier breathing. Its local action limits systemic exposure.

The specific dose and frequency are determined by the prescribing healthcare professional based on the child’s age and severity of symptoms. Typically, a few sprays per nostril are used, not exceeding the maximum daily limit recommended on the product label. Patients should follow the instructions provided by their clinician or pharmacist.

Safety of xylometazoline during pregnancy and lactation has not been established. The product is classified as pregnancy category unknown, and manufacturers advise that it should be used only if clearly needed and after consultation with a qualified healthcare provider. Breastfeeding mothers should also seek medical advice before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Xylometazoline belongs to the alpha‑adrenergic agonist class, similar to oxymetazoline and phenylephrine. Compared with phenylephrine, xylometazoline generally provides a longer duration of action and a more rapid onset of relief. Unlike oral decongestants, it acts locally, minimizing systemic side effects, but it shares the risk of rebound congestion with prolonged use.

The spray should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle away from moisture, direct sunlight and heat sources. Ensure the cap is tightly closed when not in use to maintain product stability and prevent accidental discharge.

The spray is applied directly into each nostril while the child is in an upright position. After gently shaking the bottle, insert the tip into the nostril, press the actuator to deliver the prescribed number of sprays, and repeat in the other nostril if required. Avoid blowing the nose immediately after administration to allow optimal absorption.

Although rare, serious adverse reactions can include severe hypertension, cardiac arrhythmias, and nasal ulceration. Prolonged use beyond the recommended 3‑5 days may cause rebound congestion, worsening nasal blockage after discontinuation. If any of these symptoms occur, discontinue use and seek immediate medical attention.

Children under two years of age should not use this product. Individuals with known hypersensitivity to xylometazoline or any component of the formulation should avoid it. Patients with uncontrolled hypertension, severe cardiovascular disease, or those taking monoamine oxidase inhibitors should consult a healthcare professional before use.